Group 1: Company Development and Market Expansion - The company aims to consolidate its position as a leader in the functional ingredients industry while expanding into end-consumer products, animal nutrition, and platform operations [1] - The terminal products are performing well, with increasing brand recognition and rapid growth in e-commerce sales [2] - The management is actively promoting a "three-network integration" business model to establish itself as "China's leading brand in gut health" [2] Group 2: Animal Nutrition Business - The company successfully expanded the application of oligomaltose as a new feed additive for weaned piglets, enhancing weight gain and feed efficiency [3] - The new feed additive is expected to reduce the use of preventive antibiotics and improve the safety of livestock products [3] Group 3: Product and Investment Projects - The company discussed various products such as oligomaltose, oligofructose, and dietary fibers, along with the progress of its fundraising projects [4] - The company is addressing the rising costs of corn starch, implementing strategic reserves, price adjustments, and production cost reductions [4] Group 4: Market Trends and Competitive Advantages - The fruit syrup business has seen a decline due to low sugar prices, but future market demand for fruit syrup remains promising [4] - The company has established significant competitive advantages through years of innovation, including brand recognition and product diversity [4] Group 5: International Business Development - The company is actively pursuing international certifications, which have facilitated a substantial increase in export business [5]

证券代码：002286 证券简称：保龄宝 保龄宝生物股份有限公司投资者关系活动记录表 编号：2015—004 | --- | --- | --- | |-----------------------|------------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | □√ | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ 其他 | | | 参与单位名称及 | | 国海证券股份有限公司（食品饮料行业资深分析师）余春生 | | 人员姓名 | | | | 时间 | 2015 年 7 月 19 日 | | | 地点 | 办公楼三楼会议室 | | | 上市公司接待人 员姓名 | | 李霞（董事会秘书）、张锋锋（证券事务代表） | | 投资者关系活动 | 沟通主要内容： | | | 主要内容介绍 | 一、公司的发展情况。 | | | | | 公司在巩固和发 ...

证券代码：002286 证券简称：保龄宝 保龄宝生物股份有限公司投资者关系活动记录表 编号：2015—003 | --- | --- | --- | |-----------------------|------------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | □√ | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ 其他 | | | 参与单位名称及 | | 东兴证券股份有限公司（食品饮料研究员）焦凯；光大永明 | | 人员姓名 | | 资产管理股份有限公司（研究部研究员）翟晓虹 | | 时间 | 2015 年 5 月 26 日 | | | | | | | 地点 | 办公楼三楼会议室 | | | 上市公司接待人 员姓名 | | 李霞（董事会秘书）、张锋锋（证券事务代表） | | 投资者关系活动 | 沟通主要内容： | | | 主要内容介绍 ...

Group 1: Company Development - The company aims to consolidate its position as a leader in the functional ingredients industry while expanding into end consumer products, animal nutrition, and platform operations [2] - The health industry, particularly prebiotics, is expected to have broader development prospects due to national policies, industry growth, market demand, and corporate capabilities [3] Group 2: Animal Nutrition Business - The company’s new feed additive, oligosaccharide, is currently applicable for egg-laying hens and weaned piglets, significantly improving weight gain and feed efficiency while enhancing animal immunity and reducing antibiotic use [3] - The global trend towards healthy farming is driving the development of the animal health business [3] Group 3: Ingredient Market Development - In 2014, the company faced challenges due to rising raw material prices and market competition, impacting its regular starch sugar business, while functional sugar products maintained a competitive advantage [3] - The demand for functional and efficacy-based products is expanding in 2015 [3] Group 4: End Product Business Development - The development model and channels for end products will be further strengthened, with an emphasis on new marketing channels such as micro-businesses and community marketing [4] - Enhanced consumer interaction and various marketing strategies will drive the growth of the end product business [4]

证券代码：002286 证券简称：保龄宝 编号：2016—002 保龄宝生物股份有限公司投资者关系活动记录表 | --- | --- | --- | |--------------|------------------------------|------------------------------------------------------------------------------| | | | | | 投资者关系活 | □ | 特定对象调研 □分析师会议 | | 动类别 | □ 媒体采访 □业绩说明会 | | | | □ | 新闻发布会 □√路演活动 | | | □ 现场参观 | | | | □ 其他 | | | 会议名称 | 保龄宝投资者交流暨联合调研会 | | | 参与单位名称 | | 中国人寿资产管理有限公司、民生证券、招商基金管理有限公司、太平资产管理有限 | | 及人员姓名 | | 公司、华创证券、海通并购资本、宝盈基金、国泰基金管理有限公司、同犇投资、浙江 | | | | 景裕资产管理有限公司、瑞锐投资管理咨询、深圳民森投资、银河证券、爱建证券、 | | | | 神州资本、华融金 ...

证券代码：002286 证券简称：保龄宝 编号：2020-001 保龄宝生物股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|--------------------|-------------------------------------------------| | | | | | 投资者关系活动 | □ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ | 新闻发布会 □路演活动 | | | □ 现场参观 □√ 议） | 其他 （【天风农林牧渔】保龄宝中报业绩解读电话会 | | --- | --- | |----------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：002286 证券简称：保龄宝 编号：2020-002 保龄宝生物股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------------|-------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：002286 证券简称：保龄宝 保龄宝生物股份有限公司投资者关系活动记录表 编号：2020-003 | --- | --- | --- | |-----------------------------|------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

编号：2020-004 证券代码：002286 证券简称：保龄宝 保龄宝生物股份有限公司投资者关系活动记录表 | --- | --- | --- | |-------------------------|-----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：002286 证券简称：保龄宝 编号：2021-002 保龄宝生物股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|----------------------------------------|------------------------------------------------------| | | | | | 投资者关系活动 | □√特定对象调研 □分析师会议 | | | 类别 | □媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | □现场参观 □其他 | | | 参与单位名称及 | 国金证券股份有限公司研究员：任宇超 | | | 人员姓名 | | 中信资本（深圳）投资管理有限公司研究员：杨大志 | | 时间 2021 | 年 6 月 16 日 | | | | 地点 保龄宝生物股份有限公司办公楼 | | | 上市公司接待人 员姓名 | 董事会秘书张国刚、证券事务代表张锋锋。 | | | | 1 、保龄宝基本情况介绍 | | | | 保龄宝成立于 | 1997 年，二十余年，公司 ...